This research review found that CBG, CBDV, CBC, THC-A, & THCV all showed efficacy for treating Huntington's disease, epilepsy, & Parkinson's disease.

Neuroprotective Antioxidant Properties: CBD acts as a neuroprotective antioxidant , blocking glutamate neurotoxicity with similar potency to THC.

by S Thapa · 2024 · Cited by 3 — The endocannabinoid system protects neural cells from excitotoxicity by regulating NMDAR activity, preventing overactivation and protecting ...

Cannabis compounds THC and cannabidiol (CBD) have opposing effects on brain function —and combining the two produces more muted changes than THC ...

This carboxylic acid -containing compound exhibits inherent bioactive properties, including potential anti-inflammatory and neuroprotective effects, and is ...

CBGA exhibited the strongest anticonvulsant effect in the MES threshold test , compared to the other two phytocannabinoids. · CBGA provoked seizures in the 6-Hz ...

by EB Russo · Cited by 178 — This review will examine the intriguing promise that recent discoveries regarding cannabis-based medicines offer to neurological therapeutics.

May 20, 2024 — A Comprehensive Exploration of the Multifaceted Neuroprotective Role of Cannabinoids in Alzheimer's Disease Across a Decade of Research.

Medicinal cannabis extracts are neuroprotective against Aβ1–42-mediated toxicity in vitro · CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents ...

by C Echeverry · 2023 · Cited by 4 — CBD and CBG act as neuroprotective agents by activating targets within the ECS and through mechanisms not mediated by the ECS.